Khendi White Solaru

Finished first week of cardiology consults at UH! Was amazing to work with my superstar mentee who I know from my days at CCF! Busy week but we prevailed! @TheeBlackDoctor #consultdreamteam

Truly an honor to meet this extremely talented physician speaking at Universiry Hospital grand rounds about the need for increased diversity in the cardiology workforce. @DrQuinnCapers4

Got heart? #Clevelandgoesred

DRC #Ebola outbreak is growing & at risk of spiraling out of control. We make the case for mass vaccination in areas where transmission chains cannot be followed @HarvardBiz hbr.org/2018/11/contai… @HelenBranswell @RonaldKlain @JeffDSachs @MorrisonCSIS @MackayIM @Atul_Gawande

@heatherlgornik @UHhospitals Well deserved! Enjoy your time off

Just closed the door (literally) on the first 13+ years of my medical career. Bittersweet. I’m looking forward to my next adventure (in 1/2019) with the terrific team @UHhospitals In the meantime a sabbatical: exercise, reading, time w family/friends, and some #FMD related ✍️

Thanks to Dr. Benico Barzilai for coming out to support our work on racial disparities/gender differences between Blacks and Whites with AS or BAV.

Inspiring story by AHA president Dr. Ivor Benjamin

My mentor for life! So great to see Dr. Samia Mora!

Always a pleasure to talk to these guys. Next Gen #SVM connection at AHA18 @YogenKanthi @AaronAdayMD

Bundle up. Hypertension is worse during the winter due to cold exposure.

Dr. Pulkhit and me at PVD dinner @PulkitChaudhury

PVD Council Dinner with my hubby.

In the REDUCE-IT sec/prim prev trial, icosapent ethyl (Vascepa) reduced CVD events by 25%. Researchers say this sets a new standard of care for patients with elevated triglycerides at increased CVD risk despite statins. Learn more: qoo.ly/tb5gn #AHA18

From Dr. Unkart, there is a dose response between sedentary time and odds of PAD

Dr. Jon Unkart explaining association between length of sedentary time and odds of developing PAD. Fellow Tahoe alum!

Tahoe mini-reunion at AHA

So many risk enhancing factors to consider. In particular, with ABI<.9 even if asymptomatic or triglycerides>175 consider statin therapy.

Triglycerides >175 mg/dL in nonfasting individuals best predicted incident cardiovascular events. New cholesterol guidelines reflect this! Identifying an Optimal Cutpoint for the Diagnosis of Hypertriglyceridemia in the Nonfasting State clinchem.aaccjnls.org/content/61/9/1…

New cholesterol guidelines hot off the press!! So glad that it reflects some research that I did at BWHl. Nonfasting lipids are the way to go! 2018 ACC/AHA Multisociety Guideline on the Management of Blood Cholesterol - American College of Cardiology acc.org/latest-in-card…

Cleveland Clinic HVI’s Center for Multi-Cultural Cardiovascular Care is now live under the leadership of @LeeKirkseyMD and @BenBarzilaiMD- see my.clevelandclinic.org/departments/he… for more details